

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.64909661 |
| 2 | complement activation (GO:0006956) | 8.37182760 |
| 3 | glomerular filtration (GO:0003094) | 7.39693998 |
| 4 | antibacterial humoral response (GO:0019731) | 6.96240514 |
| 5 | antimicrobial humoral response (GO:0019730) | 6.66050879 |
| 6 | renal filtration (GO:0097205) | 6.64347141 |
| 7 | protein activation cascade (GO:0072376) | 6.07732772 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.92165426 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.86702989 |
| 10 | humoral immune response (GO:0006959) | 5.48898162 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.47815057 |
| 12 | regulation of respiratory burst (GO:0060263) | 5.43238975 |
| 13 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.39101127 |
| 14 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.39101127 |
| 15 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.39101127 |
| 16 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.34973992 |
| 17 | type I interferon signaling pathway (GO:0060337) | 4.70010704 |
| 18 | cellular response to type I interferon (GO:0071357) | 4.70010704 |
| 19 | response to type I interferon (GO:0034340) | 4.66645864 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36778227 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.24267156 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.07674850 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93887485 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.91284469 |
| 25 | retina homeostasis (GO:0001895) | 3.86265579 |
| 26 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.76174673 |
| 27 | germinal center formation (GO:0002467) | 3.75829329 |
| 28 | T cell migration (GO:0072678) | 3.74910190 |
| 29 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.73292560 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.73052784 |
| 31 | regulation of cellular extravasation (GO:0002691) | 3.66043213 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63875022 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.63359989 |
| 34 | regulation of antigen processing and presentation (GO:0002577) | 3.52167859 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.51339240 |
| 36 | myeloid dendritic cell activation (GO:0001773) | 3.46763529 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44016416 |
| 38 | cellular response to interferon-gamma (GO:0071346) | 3.42244259 |
| 39 | myeloid dendritic cell differentiation (GO:0043011) | 3.36521193 |
| 40 | detection of bacterium (GO:0016045) | 3.35416369 |
| 41 | detection of other organism (GO:0098543) | 3.27550666 |
| 42 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.24020609 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.21387033 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.21387033 |
| 45 | response to interferon-gamma (GO:0034341) | 3.20366354 |
| 46 | B cell mediated immunity (GO:0019724) | 3.19823072 |
| 47 | negative regulation of myotube differentiation (GO:0010832) | 3.19727670 |
| 48 | regulation of integrin activation (GO:0033623) | 3.19361166 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16064461 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12612254 |
| 51 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.08829131 |
| 52 | defense response to Gram-negative bacterium (GO:0050829) | 3.04050518 |
| 53 | B cell homeostasis (GO:0001782) | 2.97669118 |
| 54 | production of molecular mediator of immune response (GO:0002440) | 2.96412472 |
| 55 | immune response-activating signal transduction (GO:0002757) | 2.96286591 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 2.94611060 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 2.94611060 |
| 58 | regulation of B cell differentiation (GO:0045577) | 2.93112102 |
| 59 | response to interferon-alpha (GO:0035455) | 2.92412527 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90263220 |
| 61 | activation of immune response (GO:0002253) | 2.85787784 |
| 62 | surfactant homeostasis (GO:0043129) | 2.85617079 |
| 63 | negative regulation of B cell proliferation (GO:0030889) | 2.83921472 |
| 64 | response to interferon-beta (GO:0035456) | 2.83594959 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 2.81613982 |
| 66 | positive thymic T cell selection (GO:0045059) | 2.78778018 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78330500 |
| 68 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74510659 |
| 69 | mature B cell differentiation (GO:0002335) | 2.71247067 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 2.71083117 |
| 71 | T cell lineage commitment (GO:0002360) | 2.70554636 |
| 72 | defense response to protozoan (GO:0042832) | 2.69562925 |
| 73 | negative regulation of bone resorption (GO:0045779) | 2.67816315 |
| 74 | adaptive immune response (GO:0002250) | 2.65897681 |
| 75 | chronic inflammatory response (GO:0002544) | 2.65805422 |
| 76 | dendritic cell chemotaxis (GO:0002407) | 2.65260975 |
| 77 | interferon-gamma secretion (GO:0072643) | 2.64273443 |
| 78 | lymphocyte migration (GO:0072676) | 2.62907527 |
| 79 | T cell costimulation (GO:0031295) | 2.61183484 |
| 80 | regulation of B cell proliferation (GO:0030888) | 2.60664465 |
| 81 | respiratory burst (GO:0045730) | 2.58607890 |
| 82 | lymphocyte costimulation (GO:0031294) | 2.57248468 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56242995 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56242995 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56242995 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.56242995 |
| 87 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56242995 |
| 88 | modulation by symbiont of host defense response (GO:0052031) | 2.56242995 |
| 89 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.55777909 |
| 90 | positive regulation of response to oxidative stress (GO:1902884) | 2.55777909 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55696373 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.53979283 |
| 93 | positive regulation of Rap GTPase activity (GO:0032854) | 2.51459281 |
| 94 | detection of external biotic stimulus (GO:0098581) | 2.51249761 |
| 95 | dendritic cell migration (GO:0036336) | 2.49767285 |
| 96 | protein-chromophore linkage (GO:0018298) | 2.49354603 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49331033 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 2.48647199 |
| 99 | pinocytosis (GO:0006907) | 2.47393293 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.6528847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.46552875 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.90501043 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.26046393 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19797621 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.89980664 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.54991122 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52568945 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42343910 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.07706593 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.96747574 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77744063 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77618322 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64622396 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52622240 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44638407 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38937590 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33217672 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30438403 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29663679 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20274126 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17098718 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10492201 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97719239 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.90983456 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86773990 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.85882642 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.85523859 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.83531884 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82947555 |
| 30 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.82418382 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80068391 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73525123 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73001755 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72442818 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67977098 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.65906997 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65894474 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63515752 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61779850 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.59907717 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59365440 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56585218 |
| 43 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50274664 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46233854 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42818518 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37422668 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35052015 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28025109 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26387877 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24007521 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23206113 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22913704 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21509353 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.18910470 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18392671 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16206313 |
| 57 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15537281 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13527467 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06440096 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05830798 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04938281 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03539062 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02929248 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99959937 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99816746 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98610421 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97919014 |
| 68 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95824508 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95511849 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94206446 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93891152 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92914230 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92865985 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91518022 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91268735 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90338762 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90271275 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90079373 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86082401 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81975215 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81786428 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81748284 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80446808 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79513369 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79340455 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78866443 |
| 87 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78301420 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75636169 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74354231 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.73469261 |
| 91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72252936 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71567019 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71385331 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.69631174 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.67690392 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.66819345 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66628775 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66126370 |
| 99 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.65841723 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65711355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.61986832 |
| 2 | MP0003303_peritoneal_inflammation | 3.55635564 |
| 3 | MP0005387_immune_system_phenotype | 3.47737518 |
| 4 | MP0001790_abnormal_immune_system | 3.47737518 |
| 5 | MP0003724_increased_susceptibility_to | 3.45953704 |
| 6 | MP0000685_abnormal_immune_system | 3.13111341 |
| 7 | MP0001800_abnormal_humoral_immune | 3.08029951 |
| 8 | MP0002166_altered_tumor_susceptibility | 3.04768678 |
| 9 | MP0010155_abnormal_intestine_physiology | 2.84541372 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.78979297 |
| 11 | MP0003436_decreased_susceptibility_to | 2.60374206 |
| 12 | MP0005025_abnormal_response_to | 2.52159352 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.46361995 |
| 14 | MP0009785_altered_susceptibility_to | 2.43505015 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.38716201 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.35613574 |
| 17 | MP0002006_tumorigenesis | 2.29886956 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.28950394 |
| 19 | MP0005671_abnormal_response_to | 2.28220445 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.20137191 |
| 21 | MP0003866_abnormal_defecation | 2.17531008 |
| 22 | MP0002723_abnormal_immune_serum | 2.12413342 |
| 23 | MP0001819_abnormal_immune_cell | 2.08901273 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.08822416 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.91478545 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.87183687 |
| 27 | MP0003868_abnormal_feces_composition | 1.86239487 |
| 28 | MP0002419_abnormal_innate_immunity | 1.85256190 |
| 29 | MP0005275_abnormal_skin_tensile | 1.74827857 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.74579286 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.74411649 |
| 32 | MP0005310_abnormal_salivary_gland | 1.73878475 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.71224779 |
| 34 | MP0005166_decreased_susceptibility_to | 1.69810529 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.65362287 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.63926447 |
| 37 | MP0000716_abnormal_immune_system | 1.61058158 |
| 38 | MP0002398_abnormal_bone_marrow | 1.61030632 |
| 39 | MP0001873_stomach_inflammation | 1.57274077 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.56267513 |
| 41 | MP0003045_fibrosis | 1.54986600 |
| 42 | MP0002009_preneoplasia | 1.54944053 |
| 43 | MP0004947_skin_inflammation | 1.52516072 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.46657053 |
| 45 | MP0004782_abnormal_surfactant_physiolog | 1.45574569 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.36428839 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.36391808 |
| 48 | MP0005451_abnormal_body_composition | 1.33796131 |
| 49 | MP0002429_abnormal_blood_cell | 1.32281127 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.28953288 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.27459335 |
| 52 | MP0000858_altered_metastatic_potential | 1.26287632 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.24511774 |
| 54 | MP0002722_abnormal_immune_system | 1.24189664 |
| 55 | MP0001663_abnormal_digestive_system | 1.24159162 |
| 56 | MP0003252_abnormal_bile_duct | 1.21557910 |
| 57 | MP0006082_CNS_inflammation | 1.21439960 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.20330764 |
| 59 | MP0003448_altered_tumor_morphology | 1.19644728 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.18641528 |
| 61 | MP0000477_abnormal_intestine_morphology | 1.15298216 |
| 62 | MP0000490_abnormal_crypts_of | 1.11052101 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.09251601 |
| 64 | MP0005023_abnormal_wound_healing | 1.06301687 |
| 65 | MP0005503_abnormal_tendon_morphology | 1.04844807 |
| 66 | MP0008004_abnormal_stomach_pH | 1.04788563 |
| 67 | MP0002405_respiratory_system_inflammati | 1.03581703 |
| 68 | MP0010307_abnormal_tumor_latency | 1.03539126 |
| 69 | MP0003075_altered_response_to | 1.03091420 |
| 70 | MP0000343_altered_response_to | 1.01814833 |
| 71 | MP0008469_abnormal_protein_level | 0.98456887 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.96286851 |
| 73 | MP0003091_abnormal_cell_migration | 0.96236184 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.89499839 |
| 75 | MP0003279_aneurysm | 0.87194704 |
| 76 | MP0002933_joint_inflammation | 0.86119919 |
| 77 | MP0005381_digestive/alimentary_phenotyp | 0.85946592 |
| 78 | MP0008260_abnormal_autophagy | 0.83752563 |
| 79 | MP0000604_amyloidosis | 0.83475039 |
| 80 | MP0005388_respiratory_system_phenotype | 0.83002241 |
| 81 | MP0002133_abnormal_respiratory_system | 0.83002241 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.81843298 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.80747782 |
| 84 | MP0009764_decreased_sensitivity_to | 0.78849971 |
| 85 | MP0004858_abnormal_nervous_system | 0.76216911 |
| 86 | MP0003795_abnormal_bone_structure | 0.74550273 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.73978259 |
| 88 | MP0000249_abnormal_blood_vessel | 0.70180363 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.68999391 |
| 90 | MP0005165_increased_susceptibility_to | 0.68731948 |
| 91 | MP0005164_abnormal_response_to | 0.68518737 |
| 92 | MP0005390_skeleton_phenotype | 0.67577428 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.67458882 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.64377142 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.64228574 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.63014293 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.62345148 |
| 98 | MP0001664_abnormal_digestion | 0.62183252 |
| 99 | MP0009763_increased_sensitivity_to | 0.61255731 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.60526509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of B cell number (HP:0010975) | 6.59229963 |
| 2 | Colitis (HP:0002583) | 6.58276937 |
| 3 | B lymphocytopenia (HP:0010976) | 6.42696019 |
| 4 | Agammaglobulinemia (HP:0004432) | 6.40372569 |
| 5 | Prostate neoplasm (HP:0100787) | 5.90427496 |
| 6 | Recurrent sinusitis (HP:0011108) | 5.09516137 |
| 7 | Recurrent viral infections (HP:0004429) | 4.76595767 |
| 8 | Inflammation of the large intestine (HP:0002037) | 4.68332558 |
| 9 | Cellulitis (HP:0100658) | 4.56669906 |
| 10 | Abnormality of the prostate (HP:0008775) | 4.45102218 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.44990441 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 4.42535651 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.40119906 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 4.35766492 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.35530090 |
| 16 | Vasculitis (HP:0002633) | 4.04666892 |
| 17 | Meningitis (HP:0001287) | 3.97622540 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.91531910 |
| 19 | Osteomyelitis (HP:0002754) | 3.81206951 |
| 20 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.78985809 |
| 21 | Recurrent pneumonia (HP:0006532) | 3.74946536 |
| 22 | IgM deficiency (HP:0002850) | 3.33002743 |
| 23 | Skin rash (HP:0000988) | 3.26767597 |
| 24 | Verrucae (HP:0200043) | 3.24205803 |
| 25 | Papilloma (HP:0012740) | 3.24205803 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22479442 |
| 27 | Chronic diarrhea (HP:0002028) | 3.21717296 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.20756536 |
| 29 | Recurrent lower respiratory tract infections (HP:0002783) | 3.16321773 |
| 30 | Malnutrition (HP:0004395) | 3.12052482 |
| 31 | Chronic otitis media (HP:0000389) | 3.02477539 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.01268430 |
| 33 | Abnormality of complement system (HP:0005339) | 2.99619610 |
| 34 | IgA deficiency (HP:0002720) | 2.98882608 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.91585793 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.91499532 |
| 37 | Emphysema (HP:0002097) | 2.78186516 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.75865262 |
| 39 | Hyperactive renin-angiotensin system (HP:0000841) | 2.72392389 |
| 40 | Bronchitis (HP:0012387) | 2.71441971 |
| 41 | Leukocytosis (HP:0001974) | 2.69469113 |
| 42 | Glomerulonephritis (HP:0000099) | 2.67918927 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.67065548 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.67000545 |
| 45 | Premature loss of primary teeth (HP:0006323) | 2.66956925 |
| 46 | Complement deficiency (HP:0004431) | 2.66005585 |
| 47 | Gingivitis (HP:0000230) | 2.62267350 |
| 48 | Abnormal tarsal ossification (HP:0008369) | 2.62134051 |
| 49 | Abnormality of male internal genitalia (HP:0000022) | 2.59452267 |
| 50 | Flattened epiphyses (HP:0003071) | 2.55896709 |
| 51 | Lymphopenia (HP:0001888) | 2.55313422 |
| 52 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.54928274 |
| 53 | Villous atrophy (HP:0011473) | 2.54928274 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.52831177 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.46014419 |
| 56 | Nephritis (HP:0000123) | 2.42818797 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37787043 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37787043 |
| 59 | Recurrent otitis media (HP:0000403) | 2.37161624 |
| 60 | Small epiphyses (HP:0010585) | 2.30682811 |
| 61 | Sepsis (HP:0100806) | 2.30619324 |
| 62 | Recurrent skin infections (HP:0001581) | 2.29880428 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.27526238 |
| 64 | Abnormal foot bone ossification (HP:0010675) | 2.24691946 |
| 65 | Abnormality of T cells (HP:0002843) | 2.23303685 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.16615137 |
| 67 | Hemoptysis (HP:0002105) | 2.16049520 |
| 68 | Bronchiectasis (HP:0002110) | 2.15560165 |
| 69 | Neoplasm of the lung (HP:0100526) | 2.15477161 |
| 70 | Skin ulcer (HP:0200042) | 2.15231679 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13982493 |
| 72 | Urticaria (HP:0001025) | 2.13950616 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.13288119 |
| 74 | Increased IgE level (HP:0003212) | 2.11247855 |
| 75 | Restrictive lung disease (HP:0002091) | 2.09167022 |
| 76 | Metaphyseal cupping (HP:0003021) | 2.01250627 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.00849071 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 1.96730516 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95938266 |
| 80 | Obstructive lung disease (HP:0006536) | 1.95938266 |
| 81 | Lymphoma (HP:0002665) | 1.95814861 |
| 82 | Viral hepatitis (HP:0006562) | 1.93434514 |
| 83 | Neoplasm of the respiratory system (HP:0100606) | 1.91458461 |
| 84 | Flat acetabular roof (HP:0003180) | 1.90132376 |
| 85 | Dehydration (HP:0001944) | 1.88433353 |
| 86 | Xerostomia (HP:0000217) | 1.87391533 |
| 87 | Abnormality of the peritoneum (HP:0002585) | 1.87152461 |
| 88 | Increased IgM level (HP:0003496) | 1.86516242 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 1.85983960 |
| 90 | Nasal polyposis (HP:0100582) | 1.84440125 |
| 91 | Myositis (HP:0100614) | 1.83393132 |
| 92 | Encephalitis (HP:0002383) | 1.82849112 |
| 93 | Ankyloglossia (HP:0010296) | 1.81220681 |
| 94 | Granulocytopenia (HP:0001913) | 1.80261863 |
| 95 | Decreased circulating renin level (HP:0003351) | 1.80230528 |
| 96 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.79103831 |
| 97 | Hypermelanotic macule (HP:0001034) | 1.78305652 |
| 98 | T lymphocytopenia (HP:0005403) | 1.78050501 |
| 99 | Orchitis (HP:0100796) | 1.77858954 |
| 100 | Pustule (HP:0200039) | 1.73987658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.14409722 |
| 2 | EIF2AK3 | 3.95530319 |
| 3 | TYK2 | 3.75531876 |
| 4 | PRPF4B | 3.56091063 |
| 5 | RIPK4 | 3.30849576 |
| 6 | BLK | 3.13037409 |
| 7 | FGFR4 | 3.10117467 |
| 8 | MAP4K1 | 2.92697567 |
| 9 | JAK1 | 2.84654502 |
| 10 | KIT | 2.39476614 |
| 11 | IKBKE | 2.39193171 |
| 12 | MST1R | 2.25693214 |
| 13 | FGFR3 | 2.17552606 |
| 14 | MAP3K14 | 2.16119142 |
| 15 | JAK3 | 1.91027088 |
| 16 | STK24 | 1.83538687 |
| 17 | EPHA3 | 1.77878011 |
| 18 | MAP3K10 | 1.76316691 |
| 19 | RIPK1 | 1.74866750 |
| 20 | TBK1 | 1.64541889 |
| 21 | IRAK4 | 1.57452484 |
| 22 | SYK | 1.55300228 |
| 23 | JAK2 | 1.53196899 |
| 24 | BTK | 1.46856353 |
| 25 | TAOK3 | 1.46099434 |
| 26 | BMPR2 | 1.37061257 |
| 27 | TLK1 | 1.35707022 |
| 28 | CDC42BPA | 1.34146346 |
| 29 | PKN2 | 1.33721328 |
| 30 | LYN | 1.31119251 |
| 31 | FES | 1.24584516 |
| 32 | EPHB1 | 1.21416833 |
| 33 | CSK | 1.17501737 |
| 34 | SMG1 | 1.16748600 |
| 35 | MAP3K13 | 1.15676427 |
| 36 | PIK3CA | 1.13774260 |
| 37 | ACVR1B | 1.10730077 |
| 38 | ZAP70 | 1.05700390 |
| 39 | NEK9 | 1.01654346 |
| 40 | TEC | 0.97760336 |
| 41 | CSF1R | 0.95864136 |
| 42 | TGFBR1 | 0.95141733 |
| 43 | GRK6 | 0.89252853 |
| 44 | PDGFRA | 0.86626309 |
| 45 | RPS6KA5 | 0.84543156 |
| 46 | PIM1 | 0.82837910 |
| 47 | IKBKB | 0.82383692 |
| 48 | MAP3K1 | 0.82215729 |
| 49 | HCK | 0.78574134 |
| 50 | MATK | 0.77778004 |
| 51 | IRAK1 | 0.77372403 |
| 52 | CDK6 | 0.76808057 |
| 53 | SCYL2 | 0.74752992 |
| 54 | LCK | 0.73907980 |
| 55 | STK4 | 0.73177460 |
| 56 | MELK | 0.71630594 |
| 57 | DAPK3 | 0.68889001 |
| 58 | YES1 | 0.65831393 |
| 59 | FGR | 0.65478664 |
| 60 | TNIK | 0.64700703 |
| 61 | EEF2K | 0.62621924 |
| 62 | TXK | 0.62320617 |
| 63 | MAPK11 | 0.61674642 |
| 64 | ITK | 0.61177121 |
| 65 | MAPK7 | 0.59572657 |
| 66 | FER | 0.58120657 |
| 67 | PRKCQ | 0.57207831 |
| 68 | EPHA2 | 0.56490917 |
| 69 | MAP3K5 | 0.54121572 |
| 70 | LRRK2 | 0.53778515 |
| 71 | OXSR1 | 0.50327955 |
| 72 | DDR2 | 0.50195365 |
| 73 | PIM2 | 0.49014989 |
| 74 | MAP3K8 | 0.48847010 |
| 75 | LMTK2 | 0.48314139 |
| 76 | PDPK1 | 0.47426613 |
| 77 | MAP2K3 | 0.47307674 |
| 78 | TRIB3 | 0.46573285 |
| 79 | RET | 0.46028191 |
| 80 | FYN | 0.45802834 |
| 81 | NLK | 0.44862021 |
| 82 | PDK1 | 0.44758533 |
| 83 | PRKG2 | 0.41564991 |
| 84 | PTK6 | 0.40843410 |
| 85 | PASK | 0.40586746 |
| 86 | CLK1 | 0.40064501 |
| 87 | ABL1 | 0.36255000 |
| 88 | ZAK | 0.34429745 |
| 89 | STK38L | 0.33413889 |
| 90 | MAPK4 | 0.31636582 |
| 91 | HIPK2 | 0.31415004 |
| 92 | MAPKAPK2 | 0.31183561 |
| 93 | IGF1R | 0.29637621 |
| 94 | CDK4 | 0.29390930 |
| 95 | VRK1 | 0.28989993 |
| 96 | MAP3K6 | 0.28834157 |
| 97 | PRKCD | 0.28644154 |
| 98 | CCNB1 | 0.28330861 |
| 99 | MAP3K3 | 0.25890912 |
| 100 | STK39 | 0.25791321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.76943215 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.75349912 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.61512354 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.52954403 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.49889683 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.32882220 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.19668987 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73304104 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68822128 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.44250111 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40573641 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28676449 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97233486 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93340806 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.80506629 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63544734 |
| 17 | Alcoholism_Homo sapiens_hsa05034 | 1.60921191 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.59612664 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58587878 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52178159 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50403445 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48272383 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.44982725 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39779060 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.38292764 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.29945815 |
| 27 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.29758445 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.25031366 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24347359 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14718020 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14574873 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14244106 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13685139 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99168765 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99068650 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97634759 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97295487 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94013407 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93735478 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 0.92778866 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92585252 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91328131 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.90746553 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83349628 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.83176224 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83087051 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82144654 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.81818233 |
| 49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81106733 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80304803 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79643036 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78317110 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70159798 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69115495 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69061702 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68399097 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67588496 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63733748 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63082540 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62996726 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60728711 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59765460 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56594251 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54692136 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54623155 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53527385 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.52722121 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52597097 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.52433774 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52189835 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50671564 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49758213 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48606072 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48151984 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47960204 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41707704 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40799080 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.38564221 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37674336 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36959183 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.36296605 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35690326 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34272271 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33588863 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32476138 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31986563 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29486457 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29415862 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.28152354 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27850585 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.24889778 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24258576 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.23607012 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23152255 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22811226 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21528355 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20519600 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.18534224 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18084865 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17784463 |

